Multiplex Immunofluorescence Reveals Therapeutic Targets EGFR, EpCAM, Tissue Factor, and TROP2 in Triple-Negative Breast Cancer.

When stratified by HER2 and Ki-67 status, we observed no significant differences in marker expression across the HER2-negative to low-expressing groups, although EGFR showed a trend toward higher expression in HER2-2 samples.

also in 53,322 other papers